E645-0802 Screening compound: 2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[3-(2-ethylpiperidino)propyl]acetamide

E645-0802 Screening compound: 2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[3-(2-ethylpiperidino)propyl]acetamide
E645-0802 Screening compound: 2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[3-(2-ethylpiperidino)propyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E645-0802
2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[3-(2-ethylpiperidino)propyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E645-0802

Molecular Formula

C24H29ClN4O3 (C24 H29 ClN4 O3)

Compound Name

2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[3-(2-ethylpiperidino)propyl]acetamide

IUPAC name

2-{13-chloro-9-oxo-2-oxa-410-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaen-10-yl}-N-[3-(2-ethylpiperidin-1-yl)propyl]acetamide

SMILES

CCC1N(CCCNC(CN(c(cc(cc2)Cl)c2Oc2c3cccn2)C3=O)=O)CCCC1

InChI

InChI=1S/C24H29ClN4O3/c1-2-18-7-3-4-13-28(18)14-6-12-26-22(30)16-29-20-15-17(25)9-10-21(20)32-23-19(24(29)31)8-5-11-27-23/h5,8-11,15,18H,2-4,6-7,12-14,16H2,1H3,(H,26,30)/t18-/m0/s1

InChI Key

ISMFSTQCYYATNF-SFHVURJKSA-N

MDL Number (MFCD)

MFCD14907625

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

456.97

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.230

Distribution Coefficient, logD

0.305

Water Solubility, LogSw

-3.79

Polar Surface Area

60.639

Acid Dissociation Constant (pKa)

15.74

Base Dissociation Constant (pKb)

10.32

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.80

E645-0802 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-infective Library (19449 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Dark Chemical Matter Library (18430 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Structure:
  • Pool
  • Mimetics
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with E645-0802 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E645-0802?
Check Price and Availability of E645-0802, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E645-0802 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E645-0802
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E645-0802
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E645-0802 available by request